Skip to content
Secure Enterprise UK

The Zimbabwean Government Turns Down ‘Unbalanced’ US Healthcare Assistance Package Over Data Concerns

Health funding image
The proposed US funding would have supported initiatives for HIV/Aids treatment and prevention, TB, and malarial diseases.

Zimbabwe has turned down a substantial American health deal valued at 367 million US dollars (272 million pounds) over five years over the United States' insistence on confidential data.

This move became public following a internal memorandum from December was disclosed, indicating that Head of State Emmerson Mnangagwa believed the deal was "unbalanced".

An official representative has since explained that the United States was seeking genetic material for research and profit but was not willing to share the benefits from any future treatments.

"We are forced to start the difficult and regrettable process of winding down our health assistance in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont publicly.

Her embassy noted the United States had donated over $1.9bn as health assistance to Zimbabwe over the last two decades.

A physicians' group in Zimbabwe has urged more dialogue to reach a deal acceptable to all parties so the country's critical HIV programme can proceed.

Broader Background

Zimbabwe's decision follows a similar case in neighbouring Kenya, where a high court halted a similar deal with the US following concerns were filed about the security of citizens' medical information.

Since resuming office last year, US President Donald Trump has drastically cut foreign aid and shut down the key foreign aid agency.

The agency had managed assistance for the US government, but Trump argued its expenditure was "inefficient" and his administration was pursuing direct bilateral agreements to enhance openness and responsibility.

As per statements, 16 African countries have so far signed these new agreements, constituting more than $18.3bn in new funding.

Specifics of the Rejected Agreement

The money for Zimbabwe was intended to supported "combating HIV/Aids, tuberculosis, malaria, maternal and child health, and preparing for epidemics".

"We are confident this cooperation could have provided significant benefits for Zimbabwean communities, particularly the 1.2 million men, women and children currently on antiretroviral therapy through American-funded programmes," Tremont added.

However, government spokesperson Nick Mangwana maintained the arrangement was "unequal".

"The proposal required Zimbabwe to provide its genetic material and health information indefinitely, without any corresponding assurance of benefiting from any medical innovations – such as new medicines or tests – that might result from that provided information," Mangwana explained.

"Put simply, our country would provide the raw materials for scientific discovery with no assurance that the resulting innovations would be available to our population should a future pandemic arise."

Sovereignty and Global Health

He also noted that the US's withdrawal from the World Health Organization (WHO) and its push of one-on-one deals were upending systems previously set up through the international organization.

The spokesperson gave as an example its Pathogen Access and Benefit Sharing scheme designed to deal with future pandemics.

"This mechanism is designed to guarantee that when a country provides its information, the resulting advantages – such as medicines and cures – are shared equitably, not monopolised solely by those with the funds to create them."

Zimbabwe's reservations over the US deal "should not be misconstrued as hostility towards the US," he added.

"We are open to continued discussions with our US partners on how subsequent collaboration could be designed in a way that respects the sovereignty and dignity of each country."

Medical Community Reaction

Medical experts expressed it recognised the government's concerns, but urged that negotiations need to persist since much of the nation's Aids initiatives depended on foreign aid.

"In cases where specific concerns exist, including those relating to data governance or agreement terms, these can often be resolved through detailed discussion and negotiated safeguards," the group said.

The situation underscores the complex challenges between accepting much-needed international aid and protecting a country's data in an ever more data-driven world.

SP
By

Shawn Patterson

A cybersecurity consultant with over 15 years of experience in enterprise risk management and data protection strategies across UK industries.

Secure Enterprise UK

Type to search articles.